Simplify Logo

Full-Time

Director – Global Process Validation

Confirmed live in the last 24 hours

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Hardware
Biotechnology

Senior, Expert

Bridgewater Township, NJ, USA

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • B.S. required, Ph.D. preferred in technical discipline: engineering, science, or related field
  • Minimum 10 years of industrial biologics process validation experience, CAR-T experience is highly desirable.
  • Extensive experience in an approved cell therapy program with end-to-end know-how in support of validation in a global manufacturing network
  • Candidate must have extensive experience in Cell Therapy tech transfer and/or MSAT.
  • Experience in a cross functional commercial team in driving global programs and/or initiatives
  • Experience in implementing and managing commercial process validation scope and defending this to a variety of health authorities
  • Experience in driving consistency across multiple manufacturing sites
  • Extensive knowledge in cell therapy validation industry best practices.
  • Ability to think critically and demonstrated troubleshooting and problem-solving skills.
  • Results driven with strong analytical, problem solving and critical thinking skills.
  • Strong experience working in a cross-functional organization with multiple partners with competing priorities.
  • Ability to plan, multitask, prioritize and be an effective and influential decision maker focused on action and implementation.
Responsibilities
  • Represent MSAT at joint quality and CMC committees
  • Partner closely with senior Janssen leadership to achieve global alignment on all validation Carvykti scope
  • Provide organizational leadership and support of an expanding global manufacturing network for best-in-class CAR-T product.
  • Work collaboratively with internal and external partners to drive and establish cell therapy standards, policies, procedures across the validation lifecycle
  • Align global process validation strategy, comparability plans and data governance initiatives
  • Provide critical input and review for validation master plans, PPQ and comparability protocols and reports
  • Serve as reviewer/author of a variety CMC sections or regulatory submissions, risk assessments, validation impact assessments, global change controls, draft industry guidelines, specification & critical limits
  • Serves as validation SME for Health Authority inspections and contributes to follow-up actions as part of an audit response team
  • Develop and align a variety of process validation documentation templates ranging from control strategies to PVP and PPQ templates
  • Serve as an SME for global initiatives related to quality/compliance/validation (APS benchmarking, Validation Lifecyle Responsibilities, OOS monitoring and trending program)
  • Contribute to developing and/or improvements to analytics/reporting tools and systems in support of global data systems and regulations (i.e.. datalake, 21CFRPart11 systems, front end reporting tools and templates)
  • Provide key input on standard approaches specific to cell therapy products (i.e. modified Nelson rules, Equivalence vs. Expectation)

Legend Biotech develops and sells cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments. Their goal is to provide effective treatments for hard-to-treat diseases through innovative cell therapy solutions.

Company Stage

IPO

Total Funding

$750.5M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

17%

1 year growth

38%

2 year growth

95%
Simplify Jobs

Simplify's Take

What believers are saying

  • Legend Biotech's recent European Commission approval for CARVYKTI® positions it as a leader in the multiple myeloma treatment market.
  • Strategic partnerships, such as the one with MaxCyte, enhance Legend Biotech's capabilities in cell engineering and expand its technological reach.
  • The company's commitment to transparency and investor relations, demonstrated through regular financial updates, fosters investor confidence and long-term stability.

What critics are saying

  • The competitive landscape in cell therapy and personalized medicine is intense, requiring continuous innovation to maintain market position.
  • Regulatory hurdles and the need for extensive clinical trials can delay the commercialization of new therapies, impacting revenue streams.

What makes Legend Biotech unique

  • Legend Biotech's technology-agnostic approach allows it to explore multiple innovative therapies, unlike competitors who may focus on a single technology.
  • The company's comprehensive business model, from discovery to commercialization, ensures control over the entire treatment lifecycle, providing a competitive edge.
  • Legend Biotech's strong focus on CAR-T therapies, particularly for hematological malignancies and solid tumors, sets it apart in the personalized medicine sector.